Johns Hopkins Diabetes Guide
Acetylcysteine
INDICATIONS
FDA
FDA
- Adjuvant mucolytic therapy for patients with abnormal, viscid, or inspissated mucous secretions secondary to respiratory diseases such as emphysema, tuberculosis, bronchitis or for treatment of respiratory complications of cystic fibrosis and tracheostomy care.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Nephrotoxicity prophylaxis (focus of this module)
- Acetaminophen overdose
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 3, 2020
Citation
Patel, Nisha, and Alona Crowder. "Acetylcysteine." Johns Hopkins Diabetes Guide, The Johns Hopkins University, 2020. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547001/all/Acetylcysteine.
Patel N, Crowder A. Acetylcysteine. Johns Hopkins Diabetes Guide. The Johns Hopkins University; 2020. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547001/all/Acetylcysteine. Accessed October 15, 2025.
Patel, N., & Crowder, A. (2020). Acetylcysteine. In Johns Hopkins Diabetes Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547001/all/Acetylcysteine
Patel N, Crowder A. Acetylcysteine [Internet]. In: Johns Hopkins Diabetes Guide. The Johns Hopkins University; 2020. [cited 2025 October 15]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547001/all/Acetylcysteine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Acetylcysteine
ID - 547001
A1 - Patel,Nisha,PharmD, MBA, BCPS
AU - Crowder,Alona,Pharm.D.
Y1 - 2020/07/03/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547001/all/Acetylcysteine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
